skip to content

Clinical Trials

MainTitle

No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks

This study has been completed
Sponsor
Centers for Disease Control and Prevention

Collaborator
Education Development Center, Inc.
Callen-Lorde Community Health Center
Hispanic AIDS Forum, Inc.

Information provided by (Responsible Party)
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier
NCT00690690

First received: June 3, 2008
Last updated: March 8, 2010
Last Verified: March 2010
History of Changes
Purpose

Purpose

The overall goal of this study is to develop and evaluate a brief, video-based, group-level intervention designed to reduce sexual risk taking among culturally diverse English- and Spanish-speaking Latino men who have sex with men (MSM).

Condition Intervention Phase
HIV Infections

Behavioral : Video (group-delivered video-based intervention)
Behavioral : HCT
Phase 2
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures

  • Sexual risk behavior [ Time Frame: past 3 months ]

Enrollment: 370
Study Start Date: June 2008
Study Completion Date: November 2009
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
Experimental: video

Behavioral: Video (group-delivered video-based intervention)

group-delivered video-based intervention

Active Comparator: HCT
Offer of HIV counseling and testing
Behavioral: HCT

Offer of HIV counseling and testing

Eligibility

Eligibility

Ages Eligible for Study: 18 Years to 49 Years  
Sexes Eligible for Study: Male  
Accepts Healthy Volunteers: Yes  

Criteria

Inclusion Criteria:

  • Be between the ages of 18 - 49
  • Self-identify as Latino or Hispanic
  • Speak English and/or Spanish
  • Reside in NYC and not plan to move in the next 3 months
  • Have had 2 or more sex partners in the last 3 months
  • Have had at least 1 male sex partner in the last 3 months
  • Have engaged in unprotected anal intercourse with at least one male partner in the last 3 months
  • Be HIV negative or not know their status


Exclusion Criteria:
  • Participated in a program (research or non-research) during the past 6 months where they have received HIV prevention education (e.g. an in-person or online group session, workshop, support group).
  • Report being HIV-positive

contacts and locations

Contacts and Locations

Choosing to participate in a study is an important personal decision.Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00690690

Locations

United States, New York
Education Development Center, Inc.
New York City, New York, United States, 10014

Sponsors and Collaborators

Centers for Disease Control and Prevention
Education Development Center, Inc.
Callen-Lorde Community Health Center
Hispanic AIDS Forum, Inc.

Investigators

Principal Investigator: Lydia O'Donnell, PhD Education Development Center, Inc.
More Information

More Information


Responsible Party: Education Development Center, Inc., Lydia O'Donnell  
ClinicalTrials.gov Identifier: NCT00690690   History of Changes  
Other Study ID Numbers: CDC-NCHHSTP-5142  
Study First Received: June 3, 2008  
Last Updated: March 8, 2010  

Keywords provided by Centers for Disease Control and Prevention:

HIV Seronegativity
HIV risk behavior
Unprotected sex
men who have sex with men
gay
Latino
unsafe sex
high risk sex

Additional relevant MeSH terms:
HIV Infections

ClinicalTrials.gov processed this data on October 18, 2017
This information is provided by ClinicalTrials.gov.